Document is current
Any future updates will be listed below
-
Authors
Khene, Zine-Eddine
Tachibana, Isamu
Bertail, Theophile
Fleury, Raphael
Bhanvadia, Raj
Kapur, Payal
Rajaram, Satwik
Guo, Junyu
Christie, Alana
Pedrosa, Ivan
Lotan, Yair
Margulis, Vitaly https://orcid.org/0000-0002-5837-4561
- License Information
-
More Information
Article History
Received: 17 May 2024
Accepted: 27 August 2024
First Online: 26 September 2024
Declarations
:
: The protocol was submitted to PROSPERO (CRD42023392310).
: Not required. No individual data were used in this study.
: Yair Lotan Consultant: Nanorobotics, C2I genomics, Photocure, Astra-Zeneca, Merck, Fergene, Abbvie, Nucleix, Ambu, Seattle Genetics, Hitachi, Ferring Research, verity pharmaceutics, virtuoso surgical, Stimit, Urogen, Vessi medical, CAPs medical, Xcures, BMS, Nonagen, Aura Biosciences, Inc., Convergent Genomics, Pacific Edge, Pfizer, Phinomics Inc, CG oncology, Uroviu, On target lab, Promis Diagnostics, Valar labs, Uroessentials.
